( Montvale, NJ) – Feb. 9, 2010 – The PDR Network, already the largest distributor of FDA-approved drug information, Alerts and REMS programs to physicians, has added two top regulatory and risk executives to its management team and expanded its REMS and pharmaceutical risk offerings.
Christine Côté, MD, has joined PDR Network as the Chief Medical Officer. Dr. Côté has over 24 years experience at Johnson & Johnson and Zeneca Pharmaceuticals, where she held several senior regulatory, clinical and strategic positions including Chief Scientific Officer for J&J’s Janssen Pharmaceutica division. Also during her time at J&J, Dr. Côté was directly involved with the creation of the Health Care Notification Network, now operated by PDR Network, which sends drug Alerts and REMS programs to U.S. physicians electronically, replacing paper notifications and traditional Dear Doctor Letters.
John Loucks has joined PDR Network’s senior management team as the Vice President of Sales. Mr. Loucks was previously the Chief Customer Officer for Relsys, the drug safety solutions company recently acquired by Oracle Corporation. During his time at Relsys, Mr. Loucks assisted in the development, sale and implementation of Relsys’ Argus Safety™, which is the number one drug safety system used by pharmaceutical manufacturers worldwide.
Dr Côté and Mr. Loucks join the team at PDR Network as part of the expansion of medication risk and REMS services that communicate directly with all prescribing U.S. physicians. PDR Network is the largest distributor of FDA-required REMS programs for pharmaceutical firms, having delivered over three million REMS and drug Alerts to physicians and other prescribers in the past two years.
For more information about PDR Network, visit www.pdrnetwork.com.